United States· US:0093-8741_e7a9997c-4cf7-4cf1-94c0-ff60f15ae0f9
Mexiletine Hydrochloride
A mexiletine product containing mexiletine hydrochloride, registered in United States by Teva Pharmaceuticals USA, Inc.. The same ATC class is registered in 13 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Mexiletine is registered in 13 of 19 countries.
Countries holding a registration under ATC C01BB02 (mexiletine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 7 of them publish a price we can compare per daily dose
Mexiletine · ATC C01BB02
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Japan
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of mexiletine costs, country by country.
Normalised to the WHO defined daily dose (0.8 g), so markets compare like for like.
- United States: $1.19 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Mexiletine · price per daily dose (0.8 g)
USD · FX 28 Sept 2026
- US United States$1.19 (acquisition cost)
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- MEXILETINE HYDROCHLORIDE
- Manufacturer
- Teva Pharmaceuticals USA, Inc.
- Country
- United States (US)
- ATC code
- C01BB02
- ATC class
- Mexiletine
- Defined daily dose
- 0.8 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc110093874101100 CAPSULE in 1 BOTTLE (0093-8741-01)
- ndc110093-8741-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
134 interactions on record for mexiletine.
Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Mexiletine · interactions on record
134 records
- 7 severe
- 70 moderate
- 5 minor
- 52 info
Most severe, free to view
- TheophyllinC01EB28severe
- BupropionN06AX12severe
- BupropionN07BA02severe
- TheophyllineR03DA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Mexiletine in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayMexiletine tevaTeva Pharmaceuticals
- United KingdomMexiletine 100mg tabletsSpecial Order
- CzechiaNAMUSCLALupin Europe GmbH, Frankfurt am Main
- FinlandDopitalMacure Pharma ApS
- SwedenDopital 100 mg Kapsel, hårdMACURE PHARMA ApS
- CanadaMINT-MEXILETINEMINT PHARMACEUTICALS INC
- BelgiumNamuscla 167 mgLupin Europe
- IcelandNamusclaLupin Europe GmbH
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Germany · Zunmyro, Zunmyro 200 Mg Hartkapseln
- Denmark · Dopital
- Finland · Dopital
- France · Makmorsa
- United Kingdom (Northern Ireland) · Mexiletine Hydrochloride Clinigen Healthcare, Mexiletine Hydrochloride Waymade
- Hungary · Ritalmex
- Norway · Dopital
- Sweden · Dopital
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b1623c56-3d4f-437d-960c-97a6029f5aea GET /v1/drugs/b1623c56-3d4f-437d-960c-97a6029f5aea?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "250",
"substance": "MEXILETINE HYDROCHLORIDE",
"productndc": "0093-8741",
"dosage_form": "CAPSULE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA074377",
"marketing_category": "ANDA"
}See everything about mexiletine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.